Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out
Get this document free

Health Canada approves Rayner Aspheric Intraocular Lenses For Cataract Patients

VIEWS: 85 PAGES: 1

									Health Canada approves Rayner Aspheric
Intraocular Lenses For Cataract Patients

I-MED Surgical, a division of I-MED Pharma, announced today that Health Canada has granted approval of
the Rayner C-flex® and Superflex® aspheric intraocular lenses for visual correction following cataract
surgery. As the exclusive Canadian distributor, I-MED Surgical will begin a phased commercial launch of
these new lenses with full distribution expected by Q4 2010.

Rayner C-flex Aspheric and Superflex® Aspheric IOLs are spherically aberration-neutral with the aspheric
modification being applied to the anterior surface of the IOL, providing uniform refractive power from the
centre of the optic to its edge, for optimal visual outcomes. The depth of field of this lens is very similar to
standard IOLs whilst having the advantages discussed above. In addition, the Rayner C-flex Aspheric and
Superflex® Aspheric IOLs offer the technology of the existing IOL platform. These include the Amon-Apple
Enhanced Square Edge for exemplary low posterior capsular opacification rates, AVH (anti-vaulting haptic)
Technology for optimal centration, and a single use Soft-tipped injector capable of IOL insertion through a
sub 3mm incision.

The Rayner C-flex (970C) Aspheric and Superflex® (920H) Aspheric • Increased contrast sensitivity •
Increased functional visual acuity • Optimised visual outcomes even under reduced lighting conditions •
Increased depth of field compared with designs corrected for corneal spherical aberration, such as negative
aberration designs • Less susceptible to the effects of tilt and decentration compared with negative aberration
designs – a benefit which is further enhanced by the incorporation of AVH Technology®.

“The addition of the Rayner aberration-neutral optic technology intraocular lens (IOL) selection to our offering
allows I-MED Surgical to provide our clients a complete and totally innovative IOL line which permits the
surgeon to offer their patients the most modern and effective corrective implantable lenses following cataract
surgery,” said Dr. Ilan Hofmann, President, I-MED Pharma. “The design, IOL material, optics and delivery
system is unmatched in quality and performance by any other supplier currently on the market. I-MED
Surgical, a company with more than two decades of experience in the ophthalmic surgical market, is pleased
to offer Canadian ophthalmologists the best selection of intraocular lenses manufactured by Rayner, the
company that invented intraocular lenses.”

About I-MED

I-MED Pharma innovates and distributes medical, surgical and veterinary eye care products. I-MED remains
uniquely focused on ophthalmology and is divided into three functional business units: Animal Health,
Pharma and Surgical. It researches, develops and sources the most effective and advanced solutions to eye
disorders like cataracts, corneal transplants, dry eye, and glaucoma.

For more information please visit www.imedpharma.com




View the article here Health Canada approves Rayner Aspheric Intraocular Lenses For Cataract Patients
Courtesy of Press Release Distribution Site Online PR News




                                                       1/1

								
To top